Regulations.gov document
Reference 2 - Recent Advances in the Genetics of Schizophrenia re: Response letter from…
Supporting & Related Material · FDA-2017-P-0052 · posted Aug 14, 2018
Key facts
| Document ID | FDA-2017-P-0052-0206 |
|---|---|
| Title | Reference 2 - Recent Advances in the Genetics of Schizophrenia re: Response letter from FDA CBER to Donor Sibling Registry |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2017-P-0052 |
| Posted | Aug 14, 2018 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: